Activity of Lenalidomide in Vitro and in Vivo Models of Bortezomib-resistant Mantle Cell Lymphoma Involving the Modulation of C-myc/p27 Axis

被引：0
|
作者：
Moros, A. [1 ]
Saborit-Villarroya, I. [1 ]
Perez-Galan, P. [1 ]
Martinez, A. [2 ]
Campo, E. [2 ]
Colomer, D. [1 ]
Roue, G. [1 ]
机构：
[1] IDIBAPS, Hematooncol Dept, Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Pathol, Hematopathol Unit, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)71426-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
793
引用
收藏
页码：S188 / S189
页数：2
相关论文
共 8 条
  • [1] Activity of lenalidomide in vitro and in vivo models of bortezomib-resistant mantle cell lymphoma involving the modulation of c-myc/p27 axis
    Moros, Alexandra
    Saborit-Villarroya, Ifigenia
    Perez-Galan, Patricia
    Martinez, Antonio
    Campo, Elias
    Colomer, Dolors
    Roue, Gael
    CANCER RESEARCH, 2012, 72
  • [2] Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma
    A Moros
    V Rodríguez
    I Saborit-Villarroya
    A Montraveta
    P Balsas
    P Sandy
    A Martínez
    A Wiestner
    E Normant
    E Campo
    P Pérez-Galán
    D Colomer
    G Roué
    Leukemia, 2014, 28 : 2049 - 2059
  • [3] Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma
    Moros, A.
    Rodriguez, V.
    Saborit-Villarroya, I.
    Montraveta, A.
    Balsas, P.
    Sandy, P.
    Martinez, A.
    Wiestner, A.
    Normant, E.
    Campo, E.
    Perez-Galan, P.
    Colomer, D.
    Roue, G.
    LEUKEMIA, 2014, 28 (10) : 2049 - 2059
  • [4] Synergistic anti-tumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma
    Moros, Alexandra
    Rodriguez, Vanina
    Saborit-Villarroya, Ifigenia
    Montraveta, Arnau
    Balsas, Patricia
    Sandy, Peter
    Martinez, Antonio
    Normant, Emmanuel
    Perez-Galan, Patricia
    Campo, Elias
    Colomer, Dolors
    Roue, Gael
    CANCER RESEARCH, 2014, 74 (19)
  • [5] Antitumoral Activity of Lenalidomide in In Vitro and In Vivo Models of Mantle Cell Lymphoma Involves the Destabilization of Cyclin D1/p27KIP1 Complexes
    Moros, Alexandra
    Bustany, Sophie
    Cahu, Julie
    Saborit-Villarroya, Ifigenia
    Martinez, Antonio
    Colomer, Dolors
    Sola, Brigitte
    Roue, Gael
    CLINICAL CANCER RESEARCH, 2014, 20 (02) : 393 - 403
  • [6] Potent in vitro and in vivo anti-tumor activity of ITF2357 by modulation of c-myc related miRNA signature in human Burkitt's lymphoma
    Zappasodi, R.
    Iorio, M. V.
    Cavane, A.
    Magni, M.
    Ruggiero, G.
    Carlo-Stella, C.
    Croce, C. M.
    Gianni, A. M.
    Di Nicola, M.
    EJC SUPPLEMENTS, 2010, 8 (07): : 171 - 171
  • [7] miR-135b-5p Suppresses Androgen Receptor-Enhanced Hepatocellular Carcinoma Cell Proliferation via Regulating the HIF-2α/c-Myc/P27 Signals in vitro
    Bao, Shi-xiang
    Wang, Chun-hua
    Jin, Shuai
    Hu, Kong-wang
    Lu, Jing-tao
    ONCOTARGETS AND THERAPY, 2020, 13 : 9991 - 10000
  • [8] Novel tumor suppressor protein programmed cell death 4 (PDCD4) suppresses activity of PI3K/Akt pathway and regulates expression of p27 (Kip1) and c-myc, DAP5 and Willm's tumor (WT1) in acute myeloid leukemia
    Ozpolat, Bulent
    Akar, Ugur
    Colburn, Nancy H.
    Lopez-Berestein, Gabriel
    BLOOD, 2007, 110 (11) : 781A - 781A
1